AntalGenics, S.L. 

Innovative Sensory Neurobiology

OWNER

Philipp Tsolakis (See Profile)


Sector

Biotech

Stage

Prototyping, preclinical

Country

Spain


Innovative and unique topical anti-pruritic treatment.

Targets directly neuronal itch from its origin in the skin avoiding side effects of current therapies.

A new capsaicin-based drug to topically treat psoriatic pruritus without burning sensation and not being accummulated.

Status

Approved

IP Type

Patent

Time

16 years

Countries

Australia
Austria
Belgium
China
Denmark
Finland
France
Germany
Italy
Japan
Netherlands
South Korea
Spain
Switzerland
United Kingdom

Coverage

Product and usage

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: 21st of July

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2021 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar